Biohaven Ltd.
BHVN
$9.29
$0.171.86%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.01% | -2.73% | -71.82% | -107.37% | -73.15% |
| Total Depreciation and Amortization | 34.60% | 27.03% | 29.01% | 13.64% | 35.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.90% | -67.90% | 167.71% | 432.76% | 90.49% |
| Change in Net Operating Assets | -63.38% | 891.15% | -121.58% | -31.70% | -56.36% |
| Cash from Operations | -23.34% | -34.36% | -80.80% | -75.58% | -80.18% |
| Capital Expenditure | 83.09% | 73.49% | -47.84% | -32.84% | -55.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -200.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 245.07% | -630.81% | -165.56% | -281.31% | -23.04% |
| Cash from Investing | 240.58% | -242.59% | -169.20% | -288.69% | -23.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -56.35% | -36.15% | 173.63% | 176.43% | 128.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -811.08% | 72.66% | 84.14% | 76.47% | -100.58% |
| Cash from Financing | -19.53% | 13.83% | 257.63% | 219.84% | 30.85% |
| Foreign Exchange rate Adjustments | 126.32% | 119.56% | 120.08% | 115.09% | -233.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 364.32% | -281.63% | -2,202.32% | -1,671.86% | -150.92% |